Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1885522 · NMRA

Neumora Therapeutics, Inc.

Filing with the SEC — delisting notice SEC-reporting company Watertown, MA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Oct 30, 2026 the company disclosed a notice from its exchange (Item 3.01): Nasdaq · minimum bid price. Exchanges usually give a period to regain compliance before delisting.
  • RestructuringOn Jun 15, 2026 the company committed to an exit or disposal plan with material costs (Item 2.05).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)$237M$244M
Total assets$191M$317M
Total liabilities$87.2M$29.9M
Stockholders’ equity$104M$287M
Cash and equivalents$183M$142M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Neumora Therapeutics, Inc.
CIK
0001885522
Tickers
NMRA
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC — delisting notice
State of incorporation
Delaware
Business address
Watertown, Massachusetts
Industry (SIC)
2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Jun 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Oct 30, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Notice from the exchange: Nasdaq · minimum bid price
    Form 8-K · items 3.01 · filed Oct 30, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 2.02, 5.02, 9.01 · filed Aug 14, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 5.02, 9.01 · filed Aug 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 14, 2026 · filing
  • Restructuring or layoffs
    Form 8-K · items 1.01, 2.03, 2.05, 7.01, 8.01, 9.01 · filed Jun 15, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 7, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 7, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 30, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 30, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 6, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 6, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed May 16, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 12, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 3, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 3, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Feb 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 12, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 6, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 6, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 7, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 7, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 7, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 7, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 1, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 1, 2023 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Oct 2, 2023 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Sep 18, 2023 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Aug 25, 2023 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jan 3, 2023 · filing